The findings indicate that RRP alleviates BDS by activating the PI3K-Akt signaling pathway to modulate AKT1 and NOS3 expression, providing mechanistic insights into its therapeutic actions. The gene discussed is NOS3; the disease is Diamond-Blackfan anemia.